Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “PYRAZINES”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 289 records · Page 16Linked to original sources
PubMed1998

Pharmacokinetics of a chemoprotective agent, 2-(allylthio)pyrazine, after intravenous administration to rabbits.

The pharmacokinetics of 2-(allylthio)pyrazine (2-AP) were evaluated after intravenous administrations of the drug to rabbits. The reason for the multiple peaks in the plasma concentration of 2-AP after intravenous administration of the drug to rabbits were also investigated. After intravenous administration of 2-AP, 10, 20, and 50 mg/kg, to rabbits, the pharmacokinetic parameters of 2-AP, such as the total area under the plasma concentration-time curve from time 0 to 12 h (261, 672, and 1190 micrograms min/ml), the total body clearance (38.3, 42.0, 44.6 ml/min/kg), and the percentages of intravenous dose of 2-AP excreted in 24 h as unchanged drug (0.0306, 0.0252, and 0.0492%), were independent of the dose ranges studied. Since the amount of 2-AP excreted in 12-h bile as unchanged drug after intravenous administration of 2-AP, 20 mg/kg, was only 0.0241 +/- 0.00156%, and some of 2-AP excreted in gastrointestinal tract as unchanged drug was reabsorbed, the reason for the appearance of multiple peaks after intravenous administration of 2-AP could be at least partly due to gastrointestinal excretion of the drug.

Animals↗
PubMed1998

Radioprotective effects of 2-(allylthio)pyrazine an experimental chemopreventive agent: effects on detoxifying enzyme induction.

2-(Allylthio)pyrazine (2-AP), which is effective in suppressing constitutive and inducible cytochrome P450 2E1 expression, exhibits hepatoprotective and chemopreventive effects. The radioprotective effects of 2-AP were examined in animals in association with the expression of microsomal epoxide hydrolase (mEH) and glutathione S-transferases (GSTs). 2-AP pretreatment (100 mg/kg/day, for 2 days) prior to total body irradiation (TBI) at the dose of 8 Gy increased the 30 day survival rate of mice to 91% from 48% in TBI alone. 2-AP caused an increase in the mean survival time of mice exposed to 9 Gy of TBI. Light microscopic examinations revealed that exposure of mice to 8 Gy of gamma-ray radiation resulted in hepatocyte degeneration in the surviving animals at day 1 through day 22 with certain extents of necrosis observed at early times, whereas 2-AP pretreatment protected the liver against ionizing radiation with no hepatic necrosis being observed. Mice irradiated at the dose of 8 Gy showed time-related decreases in the counts of WBC, RBC and platelet. 2-AP treatment, however, failed to protect the peripheral blood cells against gamma-irradiation and resulted in no improvement in the ratio of myeloid to erythroid bone marrow cells, as compared to TBI alone. Northern blot analysis revealed that exposure of mice to 8 Gy of TBI plus 2-AP exhibited greater mEH and mGSTA3 mRNA levels in the liver than those with TBI alone, although mGSTP1 mRNA level failed to be altered. Studies were also extended to determine the effects of 0.5 Gy gamma-irradiation in combination with 2-AP on the expression of hepatic mEH and GST genes in rats. Whereas mEH, rGSTA2, rGSTA3 and rGSTA5 mRNA levels were elevated 2- to 2.8-fold at 24 h after 2-AP treatment at the dose of 30 mg/kg, rats exposed to both 2-AP and 0.5 Gy of irradiation showed greater relative increases in the mRNAs. 2-AP enhanced the mEH and rGSTA2 gene expression to greater extents at day 1 after irradiation than after 3-5 consecutive daily treatment. The radiation-inducible mRNA levels of rGSTA3/5 and rGSTM1/2 were affected less by 2-AP pretreatment than were those of mEH and rGSTA2. These results demonstrate that 2-AP exhibits radioprotective efficacy against gamma-ray ionizing radiation in both mice and rats, which might be associated with enhanced expression of mEH and GST genes, but not with hematological improvement.

Animals↗
PubMed1998

2-(allylthio)pyrazine inhibition of aflatoxin B1-induced hepatotoxicity in rats: inhibition of cytochrome P450 2B- and 3A2-mediated bioactivation.

2-(Allylthio)pyrazine (2-AP), a synthetic organosulfur compound, exhibits hepatoprotective and chemopreventive effects. The effects of 2-AP on aflatoxin B1 (AFB1)-induced hepatotoxicity was studied in rats. 2-AP treatment substantially reduced AFB1-induced toxicity, as evidenced by reduction in the mortality rate of animals as well as decreases in serum alanine aminotransferase and sorbitol dehydrogenase activities. AFB -induced lipid peroxidation was also significantly reduced in rats by 2-AP treatment. Studies were extended to determine whether 2-AP was active in inhibiting cytochrome P450-mediated metabolic activation of AFB1. Covalent binding of AFB1 to calf thymus DNA in the presence of S-9 fraction was inhibited by 2-AP in vitro. Hepatic microsomal pentoxyresorufin-O-depentylase and ethoxyresorufin-O-deethylase activities were also potently inhibited by 2-AP. These results demonstrated that 2-AP was effective in protecting the liver against AFB1-induced toxicity and the mechanism of chemoprotection by 2-AP might involve inhibition of the P450 2B- and 3A2-mediated metabolism of AFB1.

Aflatoxin B1↗
PubMed1999

Pharmacokinetics of a chemoprotective agent, 2-(allylthio)pyrazine, after intravenous and oral administration to rats: hepatic and gastric first-pass effects.

Pharmacokinetic parameters of 2-(allylthio)pyrazine (2-AP) were evaluated after i.v. administration of the drug (10, 20, 50, and 100 mg/kg body weight) and oral administration of the drug (10, 50, and 100 mg/kg body weight) to rats. The hepatic, gastric, and intestinal first-pass effects of 2-AP were also measured after i.v., intraportal, intraduodenal, and oral administration of the drug (10 and 50 mg/kg body weight) to rats. After i.v. administration, the pharmacokinetic parameters of 2-AP were dose-independent at the dose ranges studied. However, after oral administration, the dosenormalized total area under the plasma concentration-time curve from time zero to time infinity values (43.5, 125, and 205 microg min/ml, based on 10 mg/kg body weight) increased significantly with increasing doses. The extent of absolute oral bioavailability (F) values also increased with increasing oral doses; the values were 19. 6, 56.7, and 93.6% for 10, 50, and 100 mg/kg body weight, respectively. The oral data above could be due to saturable hepatic, gastric, and/or intestinal first-pass effects. This was proved by saturable gastric first-pass effect (the significant area under the plasma concentration-time curve from time zero to time infinity difference between oral and intraduodenal administration of 2-AP); the values were 62.6 and 26.6% at 2-AP doses of 10 and 50 mg/kg body weight, respectively. Approximately 20% of oral dose was eliminated by liver (hepatic first-pass effect) for both oral doses of 10 and 50 mg/kg body weight. However, the first-pass effects of 2-AP in the intestine, heart, and lung were almost negligible. The low F value after oral administration of 2-AP at low dose (10 mg/kg body weight) was mainly due to gastric first-pass effect in rats.

Administration, Oral↗
PubMed1997

Assignment of the Vibrations in the Near-Infrared Spectra of Phenol-OH(OD) Derivatives and Application to the Phenol-Pyrazine Complex

The near-infrared spectra (7200-3800 cm-1 ) of seven phenols OH-OD (4-CH3 , H, 4-Cl, 4-Br, 3-Br, 3,4-diCl, 3-5-diCl) are investigated at room temperature in carbon tetrachloride. The mid-infrared spectra of some phenol-OD have also been studied. Beside the first overtone of the nu(OH) stretching vibration, six absorptions disappear upon deuteration. The absorptions are assigned to combinations involving the nu(OH) stretching mode and aromatic ring vibrations, the nu(C-O) mode, or the delta(OH) mode. The anharmonicity and coupling constants are discussed. The isotopic ratio of the nu(OH) stretching fundamentals, of their first overtone, and the ratio of the anharmonicity constants are very insensitive to the nature of the phenol. The stability constants of complexes between phenols and base can be computed from several near-infrared absorptions and this is illustrated for the 3,5-dichlorophenol-pyrazine complex.

Journal Article↗
PubMed1987

Homology between the pyrazine-binding protein from nasal mucosa and major urinary proteins.

Sequence analysis of the pyrazine-binding protein from bovine olfactory mucosa reveals marked homology with a family of proteins of unknown function found in the urine of the adult male mouse and rat. In view of the dramatic biological responses to odorants transmitted in male rodent urines, it is proposed that these proteins play important roles in some aspects of odor transmission and reception.

Amino Acid Sequence↗
PubMed2005

Quantitative structure and aldose reductase inhibitory activity relationship of 1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazine-4-spiro-3'-pyrrolidine-1,2',3,5'-tetrone derivatives.

We investigate the quantitative structure-activity relationship of spirosuccinimide-fused tetrahydropyrrolo[1,2-a]pyrazine-1,3-dione derivatives acting as aldose reductase inhibitors, which contain a chiral center. The published assay data of 30 training compounds are not for optically pure enantiomer preparations but for racemic mixtures. As the physicochemical descriptors for the QSAR analysis must be evaluated for either (R)-enantiomer or (S)-enantiomer, we devise a new 'racemic' descriptor as the arithmetic mean of the (R)-enantiomer descriptor and the (S)-enantiomer descriptor. The resultant QSAR model derived from the racemic descriptors outperforms the original QSAR models. The racemic QSAR model shows that the hydrophobic character of the benzyl moiety is the major contributing factor to the aldose reductase inhibitory activity and the polar surface area descriptors modulate the inhibitory activity.

Aldehyde Reductase↗
PubMed2005

Imidazo[1,2-a]pyrazin-8-ones, imidazo[1,2-d][1,2,4]triazin-8-ones and imidazo[2,1-f][1,2,4]triazin-8-ones as alpha2/alpha3 subtype selective GABA A agonists for the treatment of anxiety.

Imidazo[1,2-a]pyrazin-8-ones, imidazo[1,2-d][1,2,4]triazin-8-ones and imidazo[2,1-f][1,2,4]triazin-8-ones are high affinity GABA(A) agonists. Compound 16d has good oral bioavailability in rat, functional selectivity for the GABA(A)alpha2 and alpha3-subtypes and is anxiolytic in a conditioned animal model of anxiety with minimal sedation observed at full BZ binding site occupancy.

Administration, Oral↗
PubMed2002

Trinuclear pyrazine-bridged ruthenium complexes: syntheses, electrochemistry, NIR-Vis spectra, and their interpretation in terms of a 5-orbital-3-parameter model.

A study of absorption spectra in the near-infrared (NIR) and visible (vis) regions of trinuclear Ru complexes containing pyrazine (pyz) as bridging ligand, trans-[(Ru(NH(3))(5)pyz)(2)Ru(NH(3))(4)](m+)(m = 6-9), is reported. The spectra were recorded on aqueous solutions containing the described species formed in situ by stoichiometric additions of a standard solution of Ce(SO(4))(2). They were interpreted in terms of a simple 5-orbital-3-parameter model which includes the effects of d-pi interaction and electronic correlation. The model is shown to account for the observed NIR-vis spectra of the complex ions. The 6+ parent species was synthesized by an improved literature method and fully characterized. The novel 8+ complex was also prepared and characterized. The 9+ ion was established to be slowly reduced by water, with dioxygen formation. Electrochemical (CV and DPV) studies were performed on the trinuclear 6+ complex, as well as on its constituent fragments [Ru(NH(3))(5)(pyz)](2+) and trans-[Ru(NH(3))(4)(pyz)(2)](2+).

Journal Article↗
PubMed2003

Crystal structures and magnetic properties of 2,3,5,6-tetrakis(2-pyridyl)pyrazine (tppz)-containing copper(II) complexes.

Four new copper(II) complexes of formula [Cu(2)(tppz)(dca)(3)(H(2)O)].dca.3H(2)O (1), [Cu(5)(tppz)(N(3))(10)](n)() (2), [[Cu(2)(tppz)(N(3))(2)][Cu(2)(N(3))(6)]](n)() (3), and [Cu(tppz)(N(3))(2)].0.33H(2)O (4) [tppz = 2,3,5,6-tetrakis(2-pyridyl)pyrazine and dca = dicyanamide anion] have been synthesized and structurally characterized by X-ray diffraction methods. The structure of complex 1 is made up of dinuclear tppz-bridged [Cu(2)(tppz)(dca)(3)(H(2)O)](+) cations, uncoordinated dca anions, and crystallization water molecules. The copper-copper separation across bis-terdentate tppz is 6.5318(11) A. Complex 2 is a sheetlike polymer whose asymmetric unit contains five crystallographically independent copper(II) ions. These units are building blocks in double chains in which the central part consists of a zigzag string of copper atoms bridged by double end-on azido bridges, and the outer parts are formed by dinuclear tppz-bridged entities which are bound to the central part through single end-on azido bridges. The chains are furthermore connected through weak, double out-of-plane end-on azido bridges, yielding a sheet structure. The intrachain copper-copper separations in 2 are 6.5610(6) A across bis-terdentate tppz, 3.7174(5) and 3.8477(5) A across single end-on azido bridges, and from 3.0955(5) to 3.2047(7) A across double end-on azido bridges. The double dca bridge linking the chains into sheets yields a copper-copper separation of 3.5984(7) A. The structure of 3 consists of centrosymmetric [Cu(2)(tppz)(N(3))(2)](2+) and [Cu(2)(N(3))(6)](2)(-) units which are linked through axial Cu.N(azido) (single end-on and double end-to-end coordination modes) type interactions to afford a neutral two-dimensional network. The copper-copper separations within the cation and anion are is 6.5579(5) A (across the bis-terdentate tppz ligand) and 3.1034(6) A (across the double end-on azido bridges), whereas those between the units are 3.6652(4) A (through the single end-on azido group) and 5.3508(4) A (through the double end-to-end azido bridges). The structure of complex 4 is built of neutral [Cu(tppz)(N(3))(2)] mononuclear units and uncoordinated water molecules. The mononuclear units are grouped by pairs to give a rather short copper-copper separation of 3.9031(15) A. The magnetic properties of 1-4 have been investigated in the temperature range 1.9-300 K. The magnetic behavior of complexes 1 and 4 is that of antiferromagnetically coupled copper(II) dimers with J = -43.7 (1) and -2.1 cm(-)(1) (4) (the Hamiltonian being H = -JS(A).S(B)). An overall ferromagnetic behavior is observed for complexes 2 and 3. Despite the structural complexity of 2, its magnetic properties correspond to those of magnetically isolated tppz-bridged dinuclear copper(II) units with an intermediate antiferromagnetic coupling (J = -37.5 cm(-)(1)) plus a ferromagnetic chain of hexanuclear double azido-bridged copper(II) units (the values of the magnetic coupling within and between the hexameric units being +61.1 and +0.0062 cm(-)(1), respectively). Finally, the magnetic properties of 3 were successfully analyzed through a model of a copper(II) chain with regular alternating of three ferromagnetic interactions, J(1) = +69.4 (across the double end-on azido bridges in the equatorial plane), J(2) = +11.2 (through the tppz bridge), and J(3) = +3.4 cm(-)(1) (across the single end-on azido bridge).

Journal Article↗
PubMed2004

Mixed valence aspects of diruthenium complexes [((L)ClRu)2(mu-tppz)]n+ incorporating 2-(2-pyridyl)azoles (L) as ancillary functions and 2,3,5,6-tetrakis(2-pyridyl)pyrazine (Tppz) as bis-tridentate bridging ligand.

Tppz [2,3,5,6-tetrakis(2-pyridyl)pyrazine]-bridged complexes [((L)ClRu)(2)(mu-tppz)]n+ with structurally similar but electronically different ancillary ligands, 2-(2-pyridyl)azoles (L), were synthesized as diruthenium(II) species. Cyclic voltammetry, EPR of paramagnetic states, and UV-vis-NIR spectroelectrochemistry show that the first two reduction processes occur at the tppz bridge and that oxidation involves mainly the metal centers. The mixed valent intermediates from one-electron oxidation exhibit moderate comproportionation constants 10(4) < K(c) < 10(5) but appear to be valence-averaged according to the Hush criterion. Redox potentials, EPR, and UV-vis-NIR results show the effect of increasing donor strength of the ancillary ligands along the sequence L(1) < L(2) < L(4) << L(3), L(1) = 2-(2-pyridyl)benzoxazole, L(2) = 2-(2-pyridyl)benzthiazole, L(3) = 2-(2-pyridyl)benzimidazolate, L(4) = 1-methyl-2-(2-pyridyl)-1H-benzimidazole. Whereas the mixed valent complexes with L(1) and L(2) remain EPR silent at 4 K, the analogues with L(4) and L(3) exhibit typical ruthenium(III) EPR signals, albeit with some noticeable ligand contribution in the case of the L(3)-containing complex. Intervalence charge transfer (IVCT) bands were found in the visible spectrum for the complex with L(3) but in the near-infrared range (at ca. 1500 nm) for the other systems.

Journal Article↗
PubMed2005

Synthesis, structure, spectroscopic properties, and photochemistry of homo- and heteropolynuclear copper(I) complexes bridged by the 2,5-bis(2-pyridyl)pyrazine ligand.

Cu(I)-Cu(I) and Cu(I)-Ru(II) dinuclear complexes bridged by the 2,5-bppz (2,5-bis(2-pyridyl)pyrazine) ligand have been prepared and characterized including the X-ray crystallographic study of the dinuclear [{CuI(PPh3)2}2(mu-2,5-bppz)](PF6)2)2CH3Cl complex: a = 13.974(2), b = 13.993(2), c = 13.537(2) A; alpha = 101.98(1), beta = 103.22(1), gamma = 113.90(1) degrees ; triclinic, P, Z = 1. The trinuclear [{(bpy)2RuII(mu-2,5-bppz)}2CuI](PF6)5 complex was also prepared, and the structure of the complex in solution was studied by spectrometric titration. The dinuclear Cu(I) complex and [(bpy)2RuII(mu-2,5-bppz)CuI(PPh3)2](PF6)5 show photoluminescence in the solid state, which should arise from MLCT states. Photochemical oxidation of the trinuclear RuII2CuI complex occurs in the presence of oxygen to give a RuII2CuII complex. The MLCT states and the redox reaction in the excited state are discussed.

Journal Article↗
PubMed2006

Five new manganese-mu-azido 2D compounds synthesized in aqueous hydrazoic acid from pyrazine derivatives.

The syntheses, structural characterization, and magnetic behavior of five new 2D manganese(II) complexes with empirical formulas [Mn(N(3))(2)(2,6-DiMepyz)(H(2)O)](n)() (1), [Mn(N(3))(2)(Etpyz)(H(2)O)](n)() (2), [Mn(N(3))(2)(H(2)O)(2)](n)()(2,3-DiMepyz)(n)() (3), [Mn(N(3))(2)(Clpyz)(2)](n)() (4), and [Mn(N(3))(2)(Ipyz)(2)](n)() (5) (pyz = pyrazine (1,4-diazine)) are reported. 1 crystallizes in the monoclinic system, space group P2(1)/c, with unit cell parameters a = 7.513(4) A, b = 17.438(7) A, c = 8.404(4) A, beta = 94.53(4) degrees , and Z = 4. 2 crystallizes in the triclinic system, space group P, with unit cell parameters a = 7.386(2) A, b = 8.434(2) A, c = 9.442(3) A, alpha = 71.82(2) degrees , beta = 72.08(2) degrees , gamma = 88.54(2) degrees , and Z = 2. 3 crystallizes in the monoclinic system, space group C2/c, with unit cell parameters a = 20.438(7) A, b = 7.711(2) A, c = 7.457(2) A, beta = 93.76(3) degrees , and Z = 4. 4 crystallizes in the orthorhombic system, space group Pbca, with unit cell parameters a = 8.600(2) A, b = 13.440(4) A, c = 24.083(7) A, and Z = 8. 5 crystallizes in the orthorhombic system, space group Pbca, with unit cell parameters a = 8.521(2) A, b = 13.787(3) A, c = 26.237(5) A, and Z = 8. The compounds 1-5 have only azido bridging ligands. In 1-3 each manganese atom is linked to the four nearest neighbors by only end-to-end azido bridges, forming square layers. 4 and 5 show alternating end-to-end and end-on azido bridges between manganese atoms. The magnetic properties of 1-5 are reported. At high temperatures the plots of chi(M) or chi(M)T vs T for the 1-3 compounds can be fitted as homogeneous 2D systems with J = -4.9, -4.4, and -3.9 cm(-)(1) for 1-3, respectively. For 1, 3, and 5 magnetic ordering and spontaneous magnetizations is achieved below T(c) = 35, 29, and 22 K, respectively, whereas 2 and 4 do not show spontaneous magnetization up to 2 K.

Journal Article↗
PubMed2006

Pyrazine as a building block for molecular architectures with PtII.

A series of pyrazine (pz) complexes containing cis-(NH(3))(2)Pt(II), (tmeda)Pt(II) (tmeda = N,N,N',N'-tetramethylethylenediamine), and trans-(NH(3))(2)Pt(II) entities have been prepared and characterized by X-ray crystallography and/or 1H NMR spectroscopy. In these compounds, the pz ligands act as monodentate (1-3) or bidentate bridging ligands (4-7). Three variants of the latter case are described: a dinuclear complex [Pt(II)]2 (4b), a cyclic tetranuclear [Pt(II)](4) complex (5), and a trinuclear mixed-metal complex [Pt2Ag] (7). Mono- and bidentate binding modes are readily differentiated by 1H NMR spectroscopy, and the assignment of pz protons in the case of monodentate coordination is aided by the observation of (195)Pt satellites. Formation of the open molecular box cis-[{(NH3)2Pt(pz)}4](NO3)8.3.67H2O (5) from cis-(NH3)2Pt(II) and pz follows expectations of the "molecular library approach" for the generation of a cyclic tetramer.

Journal Article↗
PubMed2006

2,2'-Dipyridylketone (dpk) as ancillary acceptor and reporter ligand in complexes [(dpk)(Cl)Ru(mu-tppz)Ru(Cl)(dpk)]n+ where tppz = 2,3,5,6-tetrakis(2-pyridyl)pyrazine.

The tppz-bridged diruthenium(II) complex [(dpk)(Cl)Ru(II)(mu-tppz)Ru(II)(Cl)(dpk)](ClO4)2, [2](ClO4)2, and mononuclear [(dpk)(Cl)Ru(II)(tppz)](ClO4), [1](ClO4) [tppz = 2,3,5,6-tetrakis(2-pyridyl)pyrazine, dpk = 2,2'-dipyridylketone], have been synthesized. The 260 mV separation between successive one-electron oxidation couples in [2]2+ translates to a relatively small comproportionation constant, Kc, of 2.5 x 10(4) for the intermediate. It is shown how electrochemical data (E(ox), E(red), Kc) reflect the donor/acceptor effects of ancillary ligands L in a series of systems [(L)ClRu(mu-tppz)RuCl(L)]n, particularly the competition between L and tppz for electron density from the metal. According to EPR (g1 = 2.470, g2 = 2.195, and g3 = 1.873 at 4 K) the intermediate [2]3+ is a mixed-valent Ru(II)Ru(III) species which shows a rather narrow intervalence charge transfer (IVCT) band at 1800 nm (epsilon = 1500 M(-1) cm(-1)). The width at half-height (Deltanu(1/2)) of 700 cm(-1) of the IVCT band is much smaller than the calculated value of 3584 cm(-1), obtained by using the Hush formula Deltanu(1/2) = (2310E(op))(1/2) (E(op) = 5556 cm(-1), energy of the IVCT transition) which would be applicable to localized (Class II) mixed-valent Ru(II)Ru(III) systems. Valence delocalization in [2]3+ is supported by the uniform shift of the nu(C=O) band of the N,N'-coordinated dpk ligands from 1676 cm(-1) in the Ru(II)Ru(II) precursor to 1690 cm(-1) in the Ru(2.5)Ru(2.5) form, illustrating the use of the dpk acceptor to act as reporter ligand via the free but pi-conjugated organic carbonyl group. The apparent contradiction between the moderate value of Kc and the narrow IVCT band is being discussed considering "borderline" or "hybrid" "Class II-III" concepts of mixed-valency, as well as coordination aspects, i.e., the bis-tridentate nature of the pi-acceptor bridging ligand. Altogether, the complex ions [1]+ and [2]2+ display four and five successive reduction processes, respectively, involving both tppz- and dpk-based unoccupied pi orbitals. The one-electron reduced form [2]+ has been assigned as a tppz*- radical-anion-containing species which exhibits a free-radical-type EPR signal at 4K (g(parallel) = 2.002, g(perpendicular) = 1.994) and one moderately intense ligand-based low-energy band at 965 nm (epsilon = 1100 M(-1) cm(-1)).

Journal Article↗
PubMed1996

Building Block Approach to the Construction of Long-Lived Osmium(II) and Ruthenium(II) Multimetallic Complexes Incorporating the Tridentate Bridging Ligand 2,3,5,6-Tetrakis(2-pyridyl)pyrazine.

Two classes of synthetically useful bimetallic complexes of the form [(tpy)M(tpp)RuCl(3)](PF(6)) and [(tpy)M(tpp)Ru(tpp)](PF(6))(4) have been prepared and their spectroscopic and electrochemical properties investigated (tpy = 2,2':6',2"-terpyridine, tpp = 2,3,5,6-tetrakis(2-pyridyl)pyrazine, and M = Ru(II) or Os(II)). Synthetic methods have been developed for the stepwise construction of tpp-bridged systems using a building block approach. In all four complexes, the tpp that serves as the bridging ligand is the site of localization of the lowest unoccupied molecular orbital (LUMO). The nature of the HOMO (highest occupied molecular orbital) varies depending upon the components present. In the systems of the type [(tpy)M(tpp)RuCl(3)](PF(6)), the ruthenium metal coordinated to tpp and three chlorides is the easiest to oxidize and is the site of localization of the HOMO. In contrast, for the [(tpy)M(tpp)Ru(tpp)](PF(6))(4) systems, the HOMO is based on the metal, M, that is varied, either Ru or Os. This gives rise to systems which possess a lowest lying excited state that is always a metal-to-ligand charge transfer state involving tpp but can be tuned to involve Os or Ru metal centers in a variety of coordination environments. The synthetic variation of the components within this framework has allowed for understanding the spectroscopic and electrochemical properties. Bimetallic systems incorporating this tpp ligand have long-lived excited states at room temperature (lifetimes of ca. 100 ns). The bimetallic system [(tpy)Ru(tpp)Ru(tpp)](PF(6))(4) has a longer excited state lifetime than the monometallic system from which it was constructed, [(tpy)Ru(tpp)](PF(6))(2). Details of the spectroscopic and electrochemical studies are reported herein.

Journal Article↗
PubMed1997

Synthesis and X-ray Powder Structures of Nickel(II) and Copper(II) Coordination Polymers with 2,5-Bis(2-pyridyl)pyrazine.

The reaction of 2,5-bis(2-pyridyl)pyrazine (bppz) with nickel(II) sulfate in aqueous solution yielded a binuclear complex, [Ni(2)(bppz)(H(2)O)(8)](SO(4))(2).2H(2)O (1), whose structure was solved by single-crystal methods. The compound crystallizes in the monoclinic space group P2(1)/n with a = 8.372(2) Å, b = 18.301(2) Å, c = 17.197(2) Å, beta = 97.54(2) degrees, and Z = 4. The bppz ligand chelates the two octahedrally coordinated nickel atoms through its nitrogen donors. The four remaining coordination sites are occupied by water oxygen atoms. The binuclear [Ni(2)(bppz)(H(2)O)(8)](4+) cations are held together by hydrogen bonds involving sulfate anions and water molecules. Similar reactions with nickel(II) or copper(II) chloride in less polar solvents resulted in the formation of two new coordination polymers, {[Ni(2)Cl(2)(bppz)(H(2)O)(2)(CH(3)OH)(2)]Cl(2)}(n)() (2) and [Cu(2)Cl(4)(bppz)](n)() (3). These polymers could be obtained only in microcrystalline form. Their structures were determined ab initio from X-ray powder diffraction data. The complex {[Ni(2)Cl(2)(bppz)(H(2)O)(2)(CH(3)OH)(2)]Cl(2)}(n)() (2) belongs to the triclinic space group P&onemacr; with a = 8.7014(4) Å, b = 10.1465(5) Å, c = 8.0303(3) Å, alpha = 116.095(2) degrees, beta = 112.713(3) degrees, gamma = 64.056(3) degrees, and Z = 1. The octahedral coordination of the nickel atom is achieved by two nitrogens of the ligand bppz, two chloride ions, and two oxygens from the solvent molecules. The bridging nature of the chloride ions and the bis-bidentate ligands (bppz) leads to a one-dimensional polymer. The compound [Cu(2)Cl(4)(bppz)](n)() (3) crystallizes in the monoclinic space group C2/m with a = 13.9124(5) Å, b = 6.1844(2) Å, c = 10.1572(3) Å, beta = 112.952(3) degrees, and Z = 2. The copper atoms display a distorted octahedral geometry where four of the coordination sites are occupied by chloride ions and the remaining two by nitrogen atoms of bppz. The metal atoms are bridged by two chlorine atoms and the bppz ligands, forming a two-dimensional coordination polymer.

Journal Article↗
PubMed1999

Trinuclear Zinc(II) Complexes and Polymeric Cadmium(II) Complexes with the Ligand 2,5-Bis(2-pyridyl)pyrazine: Synthesis, Spectral Analysis, and Single-Crystal and Powder X-ray Analyses.

Three zinc compounds, [ZnCl(2)(bppz)(dmf)] (1), [Zn(3)(OAc)(6)(bppz)(2)](H(2)O) (2), and [Zn(3)(Cl)(6)(bppz)(3)](H(2)O) (3), and two cadmium complexes, {[Cd(OAc)(2)(bppz)](H(2)O)(5)}(n)() (4) and [Cd(NO(3))(2)(bppz)](n)() (5), where bppz is 2,5-bis(2-pyridyl)pyrazine, have been synthesized and characterized spectroscopically and crystallographically. The mononuclear complex 1, C(17)H(17)Cl(2)N(5)OZn, crystallizes in the monoclinic space group P2(1)/c, with a = 8.654(1) Å, b = 9.500(1) Å, c = 22.997(1) Å, beta = 97.99(1) degrees, and Z = 4; R1 for 2356 observed reflections [I > 2sigma(I)] was 0.058. The zinc atom has a distorted square planar coordination sphere with the ligand bppz connected in a mono-bidentate manner. The remaining coordination sites are occupied by the chloride counterions and by an oxygen atom of a solvent molecule. The trinuclear zinc compound 2, C(40)H(38)N(8)O(12)Zn(3).H(2)O, crystallizes in the triclinic space group P&onemacr;, with a = 12.238(4) Å, b = 12.986(3) Å, c = 15.470(4) Å, alpha = 75.65(1) degrees, beta = 97.99(1) degrees, gamma = 65.98(1) degrees, and Z = 2; R1 for 4511 observed reflections [I > 2sigma(I)] was 0.07. This complex consists of a linear arrangement of three zinc atoms. The central zinc atom, located on a crystallographic inversion center, is connected by six bridging acetate groups to two symmetry-related zinc atoms. It has an almost perfect octahedral coordination environment. The outer symmetry-related zinc atoms are in a square pyramidal environment, and they coordinate to three acetate groups and to one bppz molecule in a mono-bidentate manner. Compound 3, C(42)H(30)Cl(6)N(12)Zn(3).1.25H(2)O, a cyclic zinc(II) trimer, crystallizes in the cubic space group Ia&thremacr;d, with a = 26.311(1) Å and Z = 16; R1 for 692 observed reflections [I > 2sigma(I)] was 0.038. This trinuclear complex has a perfect triangular arrangement of the zinc atoms. Each zinc atom is connected to the other two by a bppz molecule. The coordination about the metal is best described as a distorted octahedral with four long distances in the basal plane, to two chlorines and to two nitrogen atoms, and two short distances in the axial direction, to two nitrogen atoms. With Cd(II) two polymeric complexes, 4 and 5 were obtained. Compound 4, C(18)H(16)N(4)O(4)Cd.5H(2)O, crystallizes in the triclinic space group P&onemacr;, a = 9.045(1) Å, b = 10.438(1) Å, c = 12.719(1) Å, alpha = 100.48(1) degrees, beta = 95.05(1) degrees, gamma = 95.86(1) degrees, and Z = 2; R1 for 3694 observed reflections [I > 2sigma(I)] was 0.029. The analogous Cd(NO(3))(2) complex with bppz, 5, could only be obtained in microcrystalline form, and its structure was solved by the use of X-ray powder diffraction methods. Compound 5, C(14)H(10)N(6)O(6)Cd, crystallizes in the monoclinic space group C2/c, with a = 11.6601(3) Å, b = 11.9870(3) Å, c = 12.1453(3) Å, beta = 103.348(2) degrees, and Z = 4. In both 4 and 5 the cadmium atoms are bridged by the ligand bppz, so forming uniform one-dimensional coordination polymers. The cadmium ions exhibit the rare coordination number of 8, with two coordinated ligand molecules and two chelating acetate (4) or nitrate (5) groups.

Journal Article↗